Bridgebio Oncology Therapeutics Inc (BBOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BBOT | AZN | AMGN | GILD | VRTX |
| Company | Bridgebio Oncology Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 9.96 | 193.91 | 373.51 | 145.11 | 489.97 |
| High | 10.02 | 193.92 | 375.00 | 146.95 | 489.97 |
| Low | 9.29 | 191.01 | 368.50 | 143.89 | 476.57 |
| Latest | 9.28 | 191.12 | 370.16 | 146.04 | 483.92 |
| Change | -0.71 | -2.19 | -7.48 | +0.04 | -8.46 |
| % Change | -7.11% | -1.13% | -1.98% | +0.03% | -1.72% |
| Volume | 131,289 | 1,561,432 | 850,365 | 3,133,947 | 806,015 |
| 20-Day Average Volume | 253,683 | 2,044,517 | 2,500,136 | 6,674,043 | 1,476,360 |
| Previous Close | 9.99 | 193.31 | 377.64 | 146.00 | 492.38 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.27 | 202.21 | 376.60 | 148.85 | 478.56 |
| 20-Day Raw Stochastic | 1.19% | 8.43% | 28.63% | 23.10% | 58.91% |
| 20-Day Relative Strength | 39.15 | 45.24 | 52.74 | 53.36 | 53.62 |
| Weighted Alpha | -21.72 | +27.74 | +25.66 | +37.68 | +4.12 |
| Today's Opinion | 72% Sell | 56% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 72% Sell | 64% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 24% Sell | 100% Buy | 100% Buy | 100% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.76% since 03/05/26 | -3.14% since 03/05/26 | +0.64% since 03/05/26 | +0.62% since 03/05/26 | +5.12% since 03/05/26 |
| Low | 9.28 on 03/12/26 | 189.35 on 03/09/26 | 361.70 on 03/06/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 11.02 on 03/06/26 | 198.09 on 03/10/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 507.92 on 03/10/26 |
| 1-Month | |||||
| %Chg | -18.39% since 02/12/26 | -6.45% since 02/12/26 | +1.03% since 02/12/26 | -3.80% since 02/12/26 | +4.17% since 02/12/26 |
| Low | 9.28 on 03/12/26 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 11.73 on 02/13/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.95 on 02/13/26 | 507.92 on 03/10/26 |
| 3-Month | |||||
| %Chg | -25.97% since 12/12/25 | +6.49% since 12/12/25 | +16.43% since 12/12/25 | +21.30% since 12/12/25 | +7.16% since 12/12/25 |
| Low | 9.28 on 03/12/26 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 14.60 on 01/09/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| 6-Month | |||||
| %Chg | -10.30% since 09/12/25 | +20.24% since 09/12/25 | +33.85% since 09/12/25 | +27.49% since 09/12/25 | +22.78% since 09/12/25 |
| Low | 9.28 on 03/12/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 14.87 on 12/08/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 799,530 | 299,806,016 | 203,573,632 | 181,247,456 | 125,081,264 |
| Shares Outstanding, K | 80,033 | 1,550,908 | 539,068 | 1,241,421 | 254,034 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -134,040,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | -38,800,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 0.28 | 0.32 | 0.45 | 0.37 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.03 on 11/12/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 06/04/26 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.29 | 17.18 | 18.23 | 30.40 |